| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Koppikar Utpal is a Chief Financial Officer at Atara Biotherapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 3,579 | $12.53 | $44,852.03 | -2.2% | +34.5% | -62.8% | |
| Jun 8, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 5,820 | $14.06 | $81,829.20 | -3.4% | +10.9% | -57.4% | |
| May 18, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 3,616 | $14.55 | $52,612.80 | -2.1% | -14.6% | -64.7% | |
| Mar 26, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,761 | $14.58 | $25,675.38 | -1.0% | +12.0% | -36.5% | |
| Mar 2, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,461 | $16.74 | $24,457.14 | -0.8% | -17.5% | -42.1% | |
| Feb 8, 2021 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,759 | $20.39 | $35,866.01 | -1.3% | -36.1% | -26.5% | |
| Nov 17, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,469 | $19.77 | $29,048.01 | -1.1% | - | - | |
| Aug 18, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,496 | $12.09 | $18,086.64 | -1.1% | - | - | |
| Jun 9, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 3,924 | $10.18 | $39,946.32 | -2.8% | - | - | |
| May 18, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,428 | $11.22 | $16,022.16 | -1.0% | - | - |